PREMSTAETTEN, Austria–(BUSINESS WIRE)–ams spectral sensing technology chosen by optical metrology specialist ELDIM for COVID-19 (SARS-CoV-2) professional rapid testing
Author: Business Wire
Ocular Therapeutix™ To Present Data at the American Academy of Ophthalmology (AAO) 2020 Virtual Annual Meeting
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announc…
Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen® Cell Therapy for the Treatment of Dry Age-related Macular Degeneration
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell therapies for serious conditions, today announced the successful comple…
Kala Pharmaceuticals to Present at the Jefferies 2020 Virtual London Healthcare Conference
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present a…
Gyroscope Therapeutics Announces First Patient Dosed in Phase II HORIZON Trial Evaluating Investigational Gene Therapy, GT005, in People with Dry Age-Related Macular Degeneration
LONDON–(BUSINESS WIRE)– #GeneTherapy–Gyroscope Announces First Patient Dosed in Phase II HORIZON Trial Evaluating Investigational Gene Therapy, GT005, in People with Dry AMD.
Alcon Reports Third Quarter 2020 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports Third Quarter 2020 Results
Alcon Reports Third Quarter 2020 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports Third Quarter 2020 Results
Aurinia Reports Third Quarter 2020 Financial Results and Recent Operational Highlights
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Reports Third Quarter 2020 Financial Results and Recent Operational Highlights
NextGen Healthcare Launches Industry’s Next Evolution of Integrated Eye Care Technology
IRVINE, Calif.–(BUSINESS WIRE)—- $NXGN #AmbulatoryHealthcare–NextGen Healthcare’s Fully Integrated Platform Provides Optometry-Specific Workflow Enabling Providers to Efficiently Document Care of Patients
Plan Cost and Reimbursement Satisfaction Drive Overall Vision Plan Satisfaction Down, J.D. Power Finds
TROY, Mich.–(BUSINESS WIRE)–Overall customer satisfaction among vision plan members has decreased in 2020, driven by a decrease in reimbursement and plan cost. According to the J.D. Power 2020 U.S. Vision Plan Satisfaction ReportSM, released today, o…
Aerie Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Neuraly Announces Strategic Sponsored Research Agreement with the University of Pennsylvania to Explore use of NLY01 to Therapeutically Target a Neuroinflammatory Mechanism of Glaucoma
GAITHERSBURG, Md.–(BUSINESS WIRE)–Neuraly, Inc, a clinical-stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, today announced a strategic sponsored research agreement with the University of Pennsylvania t…
Aura Biosciences Announces AU-011 Data From Phase 1b/2 Clinical Trial Selected for Late Breaking Presentation at the Upcoming American Academy of Ophthalmology 2020 Virtual Annual Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage biopharmaceutical company developing a novel class of tumor targeted therapies for initial application in primary tumors such as choroidal melanoma, today announced that an abstract …
Omeros Corporation Reports Third Quarter 2020 Financial Results
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications ta…
LENSAR Reports Third Quarter 2020 Financial Results and Provides Business Update
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the third…
Ocular Therapeutix™ to Participate at Two Upcoming Investor Conferences
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today an…
OneLegacy Encourages Americans to ‘Give the Gift of Sight’ During National Eye Donation Month in November
LOS ANGELES–(BUSINESS WIRE)– #eyedonationmonth–During National Eye Donation Month, OneLegacy is encouraging others to register to be a donor and give the gift of sight.
New Alcon Innovations in Intraocular Lenses, Digital Health Solutions to be Showcased at the AAO 2020 Virtual Annual Meeting
FORT WORTH, Texas–(BUSINESS WIRE)–New Alcon Innovations in Intraocular Lenses, Digital Health Solutions to be Showcased at the AAO 2020 Virtual Annual Meeting
Masimo Founder and CEO and Co-Inventor of Measure-Through-Motion Pulse Oximetry, Joe Kiani, Awarded by the Ibero-American Society of Neonatology for Improvements to Neonatal Health in Latin America
IRVINE, Calif.–(BUSINESS WIRE)–Joe Kiani, Founder & CEO of Masimo & co-inventor of measure-through-motion pulse oximetry, was honored by SIBEN for improvements to neonatal health.
Avellino Introduces New Multiplex Respiratory Panel
MENLO PARK, Calif.–(BUSINESS WIRE)– #avellinocov2test–Avellino has launched a multi-panel RT-PCR assay that quickly and accurately detects COVID-19 and other serious respiratory viruses in a single test.